Table 1.
ALTS | CVT | NHS | All | |
---|---|---|---|---|
Characteristics | n = 1,903 | n = 4,304 | n = 939 | n = 7,146 |
Study participants included in analytic cohort | Full study population | Vaccine and control arms; Unvaccinated control group | Active follow-up cohort | |
Age (years) at enrollment, mean (SD); median (IQR) | 25.3 (7.3); 23 (20–27) |
22.3 (3.1); 22 (20–24) |
34.0 (13.7); 29 (23–41) | 24.6 (7.7); 23 (20–26) |
Age at first sexual intercourse, mean (SD); median (IQR) | 16.3 (2.4); 16 (15–18) |
17.2 (2.8); 17 (15–19) |
18.0 (3.5); 17 (16–20) |
17.1 (2.8); 17 (15–18) |
Lifetime number of sexual partners at enrollment, mean (SD); median (IQR) | 8.3 (8.6); 5 (3–10) |
2.6 (2.5); 2 (1–3) |
3.0 (2.9); 2 (1–4) |
4.2 (5.5); 2 (1–5) |
Time (in years) between age at first intercourse and enrollment, mean (SD), median (IQR) | 9.0 (7.1); 7 (4–11) |
5.7 (3.7); 5 (3–8) |
17.4 (13.8); 14 (7–24) | 8.2 (7.9); 6 (4–10) |
Incident HPV infections, n | 2,636 | 8,801 | 1,619 | 13,056 |
Prevalent HPV infections among women <30 years, n |
3,434 | 3,426 | 613 | 7,473 |
Carcinogenic HPV infections, n | 2,635 | 7,001 | 873 | 10,509 |
Non-carcinogenic HPV infections, n | 3,435 | 5,226 | 1,359 | 10,020 |
IQR = Interquartile Range; SD = Standard Deviation